No­vo re­veals more he­mo­phil­ia A da­ta show­ing su­pe­ri­or­i­ty in an­nu­al­ized bleed­ing rates

Ahead of an FDA fil­ing lat­er this year, No­vo Nordisk on Sun­day of­fered up more de­tailed he­mo­phil­ia A da­ta from its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.